|
|
||||||||
Journal of Lipid Research, Vol 29, 273-278, Copyright © 1988 by Lipid Research, Inc.
ARTICLES |
DL Sprecher, L Taam, RE Gregg, SS Fojo, DM Wilson, ML Kashyap and HB Brewer Jr
National Heart, Lung, and Blood Institute, Molecular Disease Branch, Bethesda, MD 20892.
Apolipoprotein (apo) C-II deficiency is characterized by elevated plasma triglycerides, chylomicrons, and very low density lipoproteins, as well as reduced levels of low density and high density lipoproteins. A subject with apoC-II deficiency has been identified with an apoC-II plasma level of less than 0.05 mg/dl. The plasma apoC-II in the proband was immunochemically similar to apoC-II in normal subjects when analyzed by Ouchterlony immunodiffusion, however the apoC-II had an apparently lower molecular weight and higher pI when analyzed by two- dimensional gel electrophoresis. This apoC-II variant, designated apoC- IIBethesda, was not affected by neuraminidase treatment or reduction. Two-dimensional gel electrophoresis of the plasma of the mother of the proband revealed both normal apoC-II and apoC-IIBethesda, whereas analysis of the father and two siblings revealed apoC-II of normal electrophoretic mobility. These results were interpreted as indicating that the proband was a compound heterozygote with one allele for apoC- IIBethesda inherited from the mother and an allele coding for an abnormality which results in the virtual or complete absence of plasma apoC-II from the father. This proband represents the first example of a compound heterozygote for an apolipoprotein defect associated with a dyslipoproteinemia.
This article has been cited by other articles:
![]() |
M. Dahim, W. E. Momsen, M. M. Momsen, and H. L. Brockman Specificity of the lipid-binding domain of apoC-II for the substrates and products of lipolysis J. Lipid Res., April 1, 2001; 42(4): 553 - 562. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |